3rd generation TLR4 agonist small-molecule designed for effective & safe cancer therapy

Redefining Front-Line Immunotherapy

Hepha-440
European Grant

European Grant

par | Déc 17, 2018 | Uncategorized

HEPHAISTOS-Pharma obtained a European Grant for its development program of immuno-stimulators. The Inno-Boost-LPS project aims to develop innovative immuno-stimulators, based on natural Lipopolysaccharides (LPS) derivatives, to boost the efficacy of vaccines and...